The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Betta Pharmaceuticals Co's share price is ¥37.18.
Betta Pharmaceuticals Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥6.27. Hence, Betta Pharmaceuticals Co's PS Ratio for today is 5.93.
Good Sign:
Betta Pharmaceuticals Co Ltd stock PS Ratio (=6.04) is close to 10-year low of 5.75
The historical rank and industry rank for Betta Pharmaceuticals Co's PS Ratio or its related term are showing as below:
SZSE:300558'
s PS Ratio Range Over the Past 10 Years
Min: 5.75 Med: 16.42 Max: 36.73
Current: 5.9
During the past 13 years, Betta Pharmaceuticals Co's highest PS Ratio was 36.73. The lowest was 5.75. And the median was 16.42.
SZSE:300558's PS Ratio is ranked worse than 82.4% of 1000
companies
in the Drug Manufacturers industry
Industry Median: 2.13
vs SZSE:300558: 5.90
Betta Pharmaceuticals Co Ltd has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Betta Pharmaceuticals Co was 12.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 8.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 13.90% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 14.90% per year.
During the past 13 years, Betta Pharmaceuticals Co's highest 3-Year average Revenue per Share Growth Rate was 28.20% per year. The lowest was 6.60% per year. And the median was 12.40% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Betta Pharmaceuticals Co's PS Ratio
For the Drug Manufacturers - Specialty & Generic subindustry, Betta Pharmaceuticals Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Betta Pharmaceuticals Co's PS Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Betta Pharmaceuticals Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Betta Pharmaceuticals Co's PS Ratio falls into.
Betta Pharmaceuticals Co PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Betta Pharmaceuticals Co's Share Price of today is ¥37.18. Betta Pharmaceuticals Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥6.27.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Betta Pharmaceuticals Co (SZSE:300558) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Betta Pharmaceuticals Co PS Ratio Related Terms
Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Betta Pharmaceuticals Co (SZSE:300558) Business Description
Betta Pharmaceuticals Co Ltd is a hi-tech pharmaceutical enterprise focuses on research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates through China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300558 has been successfully added to your 